AI Summary & Key Takeaways
AI InsightConclusion: VAS can be used as an effective method to evaluate early period patient satisfaction related to n-BSA method used for the tre-atment of isolated great saphenous vein treatment.
📌 3 Key Takeaways
Özet
Aim: In this study, we aimed to evaluate the early results of n-butyl cyanoacrylate ablation (n-BSA) treatment and patient satisfaction using visual analogue scale (VAS) in the treatment of isolated great saphenous vein (GSV) insufficiency. Method: Seventy-two patients with GSV diameter between 6-9 mm and a reflux time of >0.5 seconds in clinical grades of C1-C4 accor-ding to the Comprehensive Classification System for Chronic Venous Disorders (CEAP) who were treated with n-BSA percutaneous endo-venous embolization between January 2016 and July 2017 due to GSV insufficiency were enrolled in the study. Preoperative and pos-toperative 1. and 6. month evaluations were made using VAS and venous color duplex ultrasonography (CDUS). All data were retrieved retrospectively from patient files, and then evaluated. Results: Preoperative, and postoperative 1. and 6. month-VAS scores were 6.05, 1.8 and 1.66 respectively. The difference between pos-toperative 1. and 6. month-VAS scores was not significant (p>0.05), but the differences between preoperative and postoperative 1. and 6. month scores were statistically significant (p<0.001). Venous CDUS performed at postoperative 1. and 6. months showed GSV closure rates of 97% and 95% respectively. Evaluation of early period out-comes of n-BSA embolization treatment performed for isolated GSV incompetence with regard to patient satisfaction using VAS, showed significant positive relationship in preoperative and early period pos-toperative period. Conclusion: VAS can be used as an effective method to evaluate early period patient satisfaction related to n-BSA method used for the tre-atment of isolated great saphenous vein treatment.